As apocrine carcinoma of other sites had many similarities with apocrine carcinoma of the breast, the treatment regimens used to treat this rare tumor are the same as those used to treat breast cancer, including endocrine therapy, which is used in patients with positive estrogen receptor (ER+) [17, 19]. This evidence concerns the gene ESR1 and neoplasm.